Amylin and GLP-1 combination or co-agonist
Cagsema sc 2p4-0p16mg qw
CAGSEMA_SC_2p4-0p16MG_QW
- Mechanism
- Amylin analogue co-formulated with a GLP-1 receptor agonist (cagrilintide with semaglutide) or unimolecular amylin and GLP-1 agonist (amycretin)
- Trials
- 0
- Participants in these arms
- 0